AI assistant
Adicet Bio, Inc. — Director's Dealing 2021
May 7, 2021
34412_dirs_2021-05-07_fcd3e42a-6cba-4857-b444-ae99a2b7981b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2021-05-05
Reporting Person: Schor Chen (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-05 | Common Stock | S | 4426 | $13.8957 | Disposed | 100351 | Indirect |
| 2021-05-05 | Common Stock | S | 3058 | $14.7006 | Disposed | 97293 | Indirect |
| 2021-05-05 | Common Stock | S | 5312 | $13.8957 | Disposed | 120452 | Indirect |
| 2021-05-05 | Common Stock | S | 3670 | $14.7006 | Disposed | 116782 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $13.51 to $14.48, inclusive.
F3: Represents shares held directly by an irrevocable family trust having an independent trustee.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.53 to $15.04, inclusive.
F5: Represents shares held directly by an irrevocable family trust having an independent trustee.